Europe Cancer Monoclonal Antibodies Market By Application (Liver, Breast, Blood, Brain, Hodgkin’s And Non-Hodgkin’s Lymphoma, Colorectal, Leukaemia And Others) By Type (murine Antibodies, Chimeric And Humanised Antibodies And Fully Humanized Antibodies) By Conjugated Cancer Therapies And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Europe Cancer Monoclonal Antibodies Market By Application (Liver, Breast, Blood, Brain, Hodgkin’s And Non-Hodgkin’s Lymphoma, Colorectal, Leukaemia And Others) By Type (murine Antibodies, Chimeric And Humanised Antibodies And Fully Humanized Antibodies) By Conjugated Cancer Therapies And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

ID: 186 | Pages: 120 | April 2018 | Region: Europe


Overview of the Market:
The Europe Cancer Monoclonal Antibodies Market is a USD 14.11 billion market in 2018 and is estimated to reach USD 23.24 billion by 2023 with a growth rate of 10.9%. Cancer is the cause of death for millions of people around the world. Cancer, which starts from a single cell is gradually transformed to other cells by genetically transforming a normal cell to tumour. The dramatic increase in the size of cancer patients has made the pharmaceutical firms to shift their focus towards monoclonal antibodies market. The traditional way of treating cancer includes usage of drugs like chemotherapy agents which has adverse side effects. This prompted the usage of monoclonal antibodies to treat cancer.

Recent years have seen the emergence of monoclonal antibodies owing to its potentiality to offer less toxic and highly efficient alternatives to the patients. The antibodies has the ability to treat many diseases related to inflammatory, autoimmune and especially cancer. The antibodies comprises of identical cells which are clones of a single parent cells and directed towards specific targets cells. Thus monoclonal antibodies due to its specificity to target only cancer cell leaving behind the healthy one, can be a more efficient way of treating cancer than chemotherapies or drugs.

Increased prevalence of cancer disease is the primary driver for the market. It has led many pharmaceutical companies to invest heavily in monoclonal antibodies due to its customizable nature of attacking only the cancer cell. The other drivers for the market include increasing investments in R&D of genomic studies, advancements in target gene selection and genetic sequencing and specificity of antibodies to target only the cancer cells. There are also hurdles prevailing for the monoclonal antibodies market like high costs of development, strict guidelines by the governments, longer periods required for clinical trials and research & development.

Geographical Analysis: 
The Europe Monoclonal Antibodies are categorised based on its applications as Blood, Brain, Breast, colorectal, Hodgkins and Non-Hodgkins lymphoma, leukaemia and others. It is segmented by type as chimeric and humanised antibodies, fully humanised antibodies and murine antibodies. The analysis of the market is done based on the conjugated cancer therapies as ADEPT, immunocytokines, Immunolipopsome, Radioimmunotherapy and others. The Europe market based on its geographical regions is studied at United Kingdom, Germany, France, Italy and Spain.

Key Players in this Market: 
Many pharmaceutical companies and governments are funding huge sums for research & development of monoclonal drugs to use it as a tool to cure cancer. The majors firms in the industry are Bristol Myers Squibb, Amgen, Eli Lilly, Genmab, Glaxosmithklinne, Novartis, Roche, Immunogen, Seattle Genetics and Spectrum Pharmaceuticals.

  1. Introduction

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

  1. Research Methodology

                2.1 Introduction               

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

  1. Overview

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

  1. Market Segmentation

                5.1 By Application           

                                5.1.1 Liver

                                5.1.2 Breast

                                5.1.3 Brain

                                5.1.4 Blood

                                5.1.5 Hodgkins and Non-Hodgkins lymphoma

                                5.1.6 Colorectal

                                5.1.7 Leukaemia

                                5.1.8 Others

                5.2 By Type        

                                5.2.1 Murine Antibodies

                                5.2.2 Chimeric and Humanised Antibodies

                                5.2.3 Fully Humanized Antibodies

                5.3 Conjugate Cancer Therapies               

                                5.3.1 Immunoliposome

                                5.3.2 Radioimmunotherapy

                                5.3.3 ADEPT

                                5.3.4 Immunocytokines

                                5.3.5 Others

  1. Geographical Analysis

                6.1 Introduction               

                6.2 U.K 

                6.3 Spain             

                6.4 Germany     

                6.5 Italy               

                6.6 France          

  1. Strategic Analysis

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

  1. Market Leaders' Analysis

                8.1 Roche

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Amgen

                8.3 Genmab

                8.4 Glaxosmithkline

                8.5 Bristol Meyer Squibb

                8.6 Eli Lilly

                8.7 Immunogen

                8.8 Novartis

                8.9 Seattle Genetics

                8.10 Spectrum Pharmaceuticals

  1. Competitive Landscape

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

  1. Expert Opinions

                10.1 Market Outlook     

                10.2 Investment Opportunities 

     Appendix                           

  1. List of Tables
  2. List of Figures
  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Cancer Monoclonal Antibodies Market By Region, From 2018-2023 ( USD Million )
  2. Europe Cancer Monoclonal Antibodies Market By Application, From 2018-2023 ( USD Million )
  3. Europe Liver Market By Region, From 2018-2023 ( USD Million )
  4. Europe Breast Market By Region, From 2018-2023 ( USD Million )
  5. Europe Brain Market By Region, From 2018-2023 ( USD Million )
  6. Europe Blood Market By Region, From 2018-2023 ( USD Million )
  7. Europe Hodgkins and Non-Hodgkins lymphoma Market By Region, From 2018-2023 ( USD Million )
  8. Europe Colorectal Market By Region, From 2018-2023 ( USD Million )
  9. Europe Leukaemia Market By Region, From 2018-2023 ( USD Million )
  10. Europe Others Market By Region, From 2018-2023 ( USD Million )
  11. Europe Cancer Monoclonal Antibodies Market By Type, From 2018-2023 ( USD Million )
  12. Europe Murine Antibodies Market By Region, From 2018-2023 ( USD Million )
  13. Europe Chimeric and Humanised Antibodies Market By Region, From 2018-2023 ( USD Million )
  14. Europe Fully Humanized Antibodies Market By Region, From 2018-2023 ( USD Million )
  15. Europe Cancer Monoclonal Antibodies Market By Conjugate Cancer Therapies, From 2018-2023 ( USD Million )
  16. Europe Immunoliposome Market By Region, From 2018-2023 ( USD Million )
  17. Europe Radioimmunotherapy Market By Region, From 2018-2023 ( USD Million )
  18. Europe ADEPT Market By Region, From 2018-2023 ( USD Million )
  19. Europe Immunocytokines Market By Region, From 2018-2023 ( USD Million )
  20. Europe Others Market By Region, From 2018-2023 ( USD Million )
  21. Cancer Monoclonal Antibodies Market By Application, From 2018-2023 ( USD Million )
  22. Liver Market By Region, From 2018-2023 ( USD Million )
  23. Breast Market By Region, From 2018-2023 ( USD Million )
  24. Brain Market By Region, From 2018-2023 ( USD Million )
  25. Blood Market By Region, From 2018-2023 ( USD Million )
  26. Hodgkins and Non-Hodgkins lymphoma Market By Region, From 2018-2023 ( USD Million )
  27. Colorectal Market By Region, From 2018-2023 ( USD Million )
  28. Leukaemia Market By Region, From 2018-2023 ( USD Million )
  29. Others Market By Region, From 2018-2023 ( USD Million )
  30. U.K. Cancer Monoclonal Antibodies Market By Application, From 2018-2023 ( USD Million )
  31. U.K. Cancer Monoclonal Antibodies Market By Type, From 2018-2023 ( USD Million )
  32. U.K. Cancer Monoclonal Antibodies Market By Conjugate Cancer Therapies, From 2018-2023 ( USD Million )
  33. Germany Cancer Monoclonal Antibodies Market By Application, From 2018-2023 ( USD Million )
  34. Germany Cancer Monoclonal Antibodies Market By Type, From 2018-2023 ( USD Million )
  35. Germany Cancer Monoclonal Antibodies Market By Conjugate Cancer Therapies, From 2018-2023 ( USD Million )
  36. France Cancer Monoclonal Antibodies Market By Application, From 2018-2023 ( USD Million )
  37. France Cancer Monoclonal Antibodies Market By Type, From 2018-2023 ( USD Million )
  38. France Cancer Monoclonal Antibodies Market By Conjugate Cancer Therapies, From 2018-2023 ( USD Million )
  39. Italy Cancer Monoclonal Antibodies Market By Application, From 2018-2023 ( USD Million )
  40. Italy Cancer Monoclonal Antibodies Market By Type, From 2018-2023 ( USD Million )
  41. Italy Cancer Monoclonal Antibodies Market By Conjugate Cancer Therapies, From 2018-2023 ( USD Million )
  42. Spain Cancer Monoclonal Antibodies Market By Application, From 2018-2023 ( USD Million )
  43. Spain Cancer Monoclonal Antibodies Market By Type, From 2018-2023 ( USD Million )
  44. Spain Cancer Monoclonal Antibodies Market By Conjugate Cancer Therapies, From 2018-2023 ( USD Million )
Middle East & Africa Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, ...
Latin America Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Seroton...
Asia Pacific Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Serotoni...
Europe Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Serotonin-nore...
North America Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Seroton...
Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Serotonin-norepinephr...
Middle East and Africa Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables...
Latin America Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrum...
Asia-Pacific Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrume...
Europe Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instruments), ...
North America Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrum...
Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instruments), End Use...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.